Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Alpha-methylacyl-CoA racemase expression is upregulated in gastric adenocarcinoma: a study of 249 cases.

Truong CD, Li W, Feng W, Cagle P, Khoury T, Alrawi S, Xie K, Yao J, Tan D.

Int J Clin Exp Pathol. 2008 Apr 10;1(6):518-23.

2.

A dietary enzyme: alpha-methylacyl-CoA racemase/P504S is overexpressed in colon carcinoma.

Jiang Z, Fanger GR, Banner BF, Woda BA, Algate P, Dresser K, Xu J, Reed SG, Rock KL, Chu PG.

Cancer Detect Prev. 2003;27(6):422-6.

PMID:
14642549
3.

Expression of alpha-methylacyl-CoA racemase (P504s) in various malignant neoplasms and normal tissues: astudy of 761 cases.

Jiang Z, Fanger GR, Woda BA, Banner BF, Algate P, Dresser K, Xu J, Chu PG.

Hum Pathol. 2003 Aug;34(8):792-6.

PMID:
14506641
4.
5.

Alpha-Methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions.

Zhou M, Chinnaiyan AM, Kleer CG, Lucas PC, Rubin MA.

Am J Surg Pathol. 2002 Jul;26(7):926-31.

PMID:
12131161
6.
7.

Expression of alpha-methylacyl-CoA racemase (P504S) in sebaceous neoplasms.

Halsey MA, Calder KB, Mathew R, Schlauder S, Morgan MB.

J Cutan Pathol. 2010 Apr;37(4):446-51. doi: 10.1111/j.1600-0560.2009.01353.x. Epub 2009 Jul 23.

PMID:
19638170
8.

Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.

Sung MT, Jiang Z, Montironi R, MacLennan GT, Mazzucchelli R, Cheng L.

Hum Pathol. 2007 Feb;38(2):332-41. Epub 2006 Nov 28.

PMID:
17134736
9.

Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.

Luo J, Zha S, Gage WR, Dunn TA, Hicks JL, Bennett CJ, Ewing CM, Platz EA, Ferdinandusse S, Wanders RJ, Trent JM, Isaacs WB, De Marzo AM.

Cancer Res. 2002 Apr 15;62(8):2220-6.

10.

Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance.

Lin A, Weiser MR, Klimstra DS, Paty PB, Tang LH, Al-Ahmadie H, Hoo Park S, Guillem JG, Temple L, Wong WD, Gerald WL, Shia J.

Hum Pathol. 2007 Jun;38(6):850-6. Epub 2007 Apr 18.

PMID:
17442371
11.

Analysis of alpha-methylacyl-CoA racemase (P504S) expression in high-grade prostatic intraepithelial neoplasia.

Wu CL, Yang XJ, Tretiakova M, Patton KT, Halpern EF, Woda BA, Young RH, Jiang Z.

Hum Pathol. 2004 Aug;35(8):1008-13.

PMID:
15297968
12.

Alpha methylacyl-CoA racemase (AMACR) in prostate adenocarcinomas from Japanese patients: is AMACR a "race"-dependent marker?

Yamada H, Tsuzuki T, Maeda N, Yamauchi Y, Yoshida S, Ishida R, Nishikimi T, Yokoi K, Kobayashi H.

Prostate. 2013 Jan;73(1):54-9. doi: 10.1002/pros.22539. Epub 2012 May 16.

PMID:
22593005
13.
16.

Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker.

Jiang Z, Wu CL, Woda BA, Iczkowski KA, Chu PG, Tretiakova MS, Young RH, Weiss LM, Blute RD Jr, Brendler CB, Krausz T, Xu JC, Rock KL, Amin MB, Yang XJ.

Histopathology. 2004 Sep;45(3):218-25.

PMID:
15330799
17.

AMACR is highly expressed in gastric adenomas and intestinal-type carcinomas.

Cho EY, Kim KM, Park CK, Kim JJ, Sohn TS, Kim DW.

APMIS. 2007 Jun;115(6):713-8.

PMID:
17550379
18.

Peroxisomal branched chain fatty acid beta-oxidation pathway is upregulated in prostate cancer.

Zha S, Ferdinandusse S, Hicks JL, Denis S, Dunn TA, Wanders RJ, Luo J, De Marzo AM, Isaacs WB.

Prostate. 2005 Jun 1;63(4):316-23.

PMID:
15599942
19.

Discovery and clinical application of a novel prostate cancer marker: alpha-methylacyl CoA racemase (P504S).

Jiang Z, Woda BA, Wu CL, Yang XJ.

Am J Clin Pathol. 2004 Aug;122(2):275-89. Review.

PMID:
15323145
20.

Alpha-methylacyl coenzyme A racemase overexpression in gallbladder carcinoma confers an independent prognostic indicator.

Wu LC, Chen LT, Tsai YJ, Lin CM, Lin CY, Tian YF, Sheu MJ, Uen YH, Shiue YL, Wang YH, Yang SJ, Wu WR, Li SH, Iwamuro M, Kobayasshi N, Huang HY, Li CF.

J Clin Pathol. 2012 Apr;65(4):309-14. doi: 10.1136/jclinpath-2011-200489. Epub 2012 Jan 21.

PMID:
22267983

Supplemental Content

Support Center